PwC names Ron Chopoorian global leader of health industries

03 March 2021 2 min. read
More news on

PwC has appointed Ron Chopoorian as global leader of its health industries practice. The 27-year veteran of the firm will remain based in New York.

Chopoorian will now oversee a 12,000-person global team that advises healthcare and pharmaceutical clients, as well as policymakers, on topics such as patient experience, precision medicine, digital transformation, data analytics, assurance, and tax.

He will also maintain his current role as global relationship partner for a large multinational pharmaceutical firm.

Chopoorian has extensive experience advising private equity and corporate clients across the payer, provider, pharmaceutical, and life sciences industries. He has deep expertise in business and commercial strategy, and M&A and divestitures.

PwC names Ron Chopoorian global leader of health industries“The opportunities and challenges facing our clients are unparalleled,” Kevin Burrowes, PwC’s global clients and industries leader, said. “In collaboration with other industries, our Health Industries practice, under Ron’s leadership, will continue to help governments and organisations repair, rethink, and reconfigure their business models to emerge stronger from the crisis.”

Chopoorian previously served as New York Metro deals leader, and has served as a global relationship partner since 2014.

He joined the firm’s audit practice as an associate before moving on to transaction services, where he became a partner in 2005. In 2010 he founded PwC US’ divestiture services practice, which he led for four years. He also previously co-led the firm’s “Digitizing Deals” initiative which focused on integrating technology into the M&A process.

Chopoorian holds a bachelor’s degree in accounting from Southern Methodist University and an MBA from Manchester Business School. He is also a CPA.

“I’m excited to take on the role of Global Health Industries Leader during a time when clients, policymakers, and society face profound changes, challenges, and opportunities,” Chopoorian said. “The Covid-19 pandemic serves as a reminder of how PwC’s purpose - to build trust in society and solve important problems - guides our work with health industries stakeholders.